(Q28306491)

2

0 references

Haruhiko Siomi

object named as

Haruhiko Siomi

3

0 references

author name string

Mikiko C Siomi

4

0 references

Katsuhiko Yoshimoto

5

0 references

Shozo Yamada

6

0 references

Elaine Lu Wang

7

0 references

Md Mustafizur Rahman

8

0 references

Hiroshi Inoue

9

0 references

Mitsuo Itakura

10

0 references

Eiji Kudo

11

0 references

Toshiaki Sano

Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C

12

0 references

language of work or name

English

0 references

publication date

March 2009

0 references

published in

Modern Pathology

0 references

volume

22

0 references

issue

3

0 references

page(s)

431-41

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.202

Oncomirs - microRNAs with a role in cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.202

The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.202

Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.202

Identification of novel genes coding for small expressed RNAs

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.202

RAS is regulated by the let-7 microRNA family

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.202

Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.202

The tumor suppressor microRNA let-7 represses the HMGA2 oncogene

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.202

Let-7 expression defines two differentiation stages of cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.202

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.202

Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.202

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.202

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.202

let-7 microRNA functions as a potential growth suppressor in human colon cancer cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.202

Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.202

MicroRNAs: genomics, biogenesis, mechanism, and function

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.202

The pathogenesis of pituitary tumours

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.202

Mechanisms of disease: The pathogenesis of pituitary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.202

The high mobility group protein HMG I(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.202

The high mobility group protein HMG I(Y) is an essential structural component of a virus-inducible enhancer complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.202

Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.202

Roles of HMGA proteins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.202

Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.202

Sizing up miRNAs as cancer genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.202

High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.202

A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.202

Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.202

Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.202

Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.202

Molecular pathology shows p16 methylation in nonadenomatous pituitaries from patients with Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.202

Inactivation of RASSF1A tumor suppressor gene by aberrant promoter hypermethylation in human pituitary adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.202

Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.202

The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.202

Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.202

Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.202

High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.202